| Kenel Fernandes Barbosa, MD | |
|
Instituto San Palbo Ofic 509, Bayamon, PR 00961 | |
| (787) 269-4670 | |
| (787) 269-4740 |
| Full Name | Kenel Fernandes Barbosa |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 49 Years |
| Location | Instituto San Palbo Ofic 509, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104919166 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 7336 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doctors' Center Hospital, Inc | Manati, PR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bayamon Oncology Medical Csp | 6406227610 | 2 |
| Doctor's Center Hematology And Oncology Group, Psc | 4789765587 | 3 |
| Doctors Center Hematology And Oncology Group Bayamon Psc | 3678638707 | 3 |
News Archive
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress.
The German Institute for Quality and Efficiency in Health Care challenges the language barriers in health and launches Europe's first bilingual evidence-based health information website.
The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.
› Verified 6 days ago
| Entity Name | Cdt Gmsp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417922972 PECOS PAC ID: 1355317751 Enrollment ID: O20040908000092 |
News Archive
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress.
The German Institute for Quality and Efficiency in Health Care challenges the language barriers in health and launches Europe's first bilingual evidence-based health information website.
The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.
› Verified 6 days ago
| Entity Name | Doctor's Center Hematology & Oncology Group, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982608618 PECOS PAC ID: 4789765587 Enrollment ID: O20080118000011 |
News Archive
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress.
The German Institute for Quality and Efficiency in Health Care challenges the language barriers in health and launches Europe's first bilingual evidence-based health information website.
The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.
› Verified 6 days ago
| Entity Name | Doctors Center Hematology & Oncology Group Bayamon Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629248604 PECOS PAC ID: 3678638707 Enrollment ID: O20090224000436 |
News Archive
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress.
The German Institute for Quality and Efficiency in Health Care challenges the language barriers in health and launches Europe's first bilingual evidence-based health information website.
The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.
› Verified 6 days ago
| Entity Name | Bayamon Oncology Medical Csp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043603889 PECOS PAC ID: 6406227610 Enrollment ID: O20230126002014 |
News Archive
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress.
The German Institute for Quality and Efficiency in Health Care challenges the language barriers in health and launches Europe's first bilingual evidence-based health information website.
The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenel Fernandes Barbosa, MD Buzon 6310 Santa Rosa Station, Bayamon, PR 00960 Ph: (787) 269-4740 | Kenel Fernandes Barbosa, MD Instituto San Palbo Ofic 509, Bayamon, PR 00961 Ph: (787) 269-4670 |
News Archive
The heart is capable of terminating arrhythmias itself after local gene therapy, potentially avoiding the need for patients to undergo painful electric shocks, according to a proof-of-concept study presented today at EHRA 2018, a European Society of Cardiology congress.
The German Institute for Quality and Efficiency in Health Care challenges the language barriers in health and launches Europe's first bilingual evidence-based health information website.
The U.S. Food and Drug Administration has approved the biologic drug etanercept (brand name Enbrel) to treat chronic, moderate to severe plaque psoriasis in adults.
The newly launched Pulmonary Fibrosis Foundation Patient Communication Center (PCC) has become the destination for the most up-to-date information for the pulmonary fibrosis community. The PCC now has information about the Expanded Access Program (EAP) for pirfenidone.
The International Federation of Psoriasis Associations, IFPA, commends the World Health Organization for raising awareness of the risks associated with high blood pressure and calls for healthcare professionals to regularly scan for the condition in patients with psoriasis.
› Verified 6 days ago
Jannette Marie Figueroa-velez, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif Dr Arturo Cadilla Vinas Suite 104, Bayamon, PR 00960 Phone: 787-269-2442 | |
Dr. Ana I Rivera De La Vega, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 100 Paseo San Pablo, Edif. Dr. Arturo Cadilla, Suite 201, Bayamon, PR 00961 Phone: 787-778-8774 Fax: 787-269-6190 | |
Boris M Guzman-hernandez, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Mq10 Plaza 37, Monte Claro, Bayamon, PR 00961 Phone: 787-245-8870 Fax: 787-858-0434 | |
Jose M Rodriguez Castro, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Edif Metromedical, A- 608, Bayamon, PR 00959 Phone: 787-395-7125 Fax: 787-395-7126 | |
Dalvert H Polanco, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 100 Ave Laurel, Bayamon, PR 00956 Phone: 787-787-5151 | |
Dr. Isabel E Cestero, M. D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Route #2 Km 11.7 Bayamon Medical Plaza, Suite 409-b, Bayamon, PR 00959 Phone: 787-786-0473 Fax: 787-786-9718 | |
Joham Senior Marino, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: Piso 1 Suite 104a, Bayamon Medical Plaza, Bayamon, PR 00960 Phone: 787-798-9522 Fax: 787-798-9500 |